TrialCancer2025

Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study.

Xia Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.